Petition to Save Disposable E-cigarettes and Fruit Flavors

Regulations by 2FIRSTS.ai
Dec.11.2023
Petition to Save Disposable E-cigarettes and Fruit Flavors
UKVIA urges smokers, e-cigarette users, and industry professionals to petition against UK government banning disposable and fruit-flavored e-cigarettes.

In recent days, according to an announcement on the official website of the UK Vaping Industry Association (UKVIA), the organization is making an unprecedented call for smokers, e-cigarette users, and stakeholders in the industry nationwide to unite and launch a petition. The aim is to urge the UK government not to ban the sale of disposable e-cigarettes and e-cigarettes with fruit flavors.

 

The commencement of this petition campaign is closely tied to the ongoing public consultation on the issue of youth e-cigarette usage. The open consultation will conclude on December 6th.

 

This petition reveals to the general public the potentially severe public health consequences of "excessive and counterproductive legislation" that could undermine the effectiveness of e-cigarettes as a smoking cessation tool. It warns that blocking access to fruit-flavored e-cigarettes and disposable e-cigarettes could deter adult smokers from transitioning to e-cigarettes, as the majority of smokers who want to quit depend on these flavors and disposable options.

 

In light of this, the UK e-cigarette industry association is currently engaging directly with its members, advocacy groups such as WeVape, and online communities with over 100,000 adult e-cigarette users, urging them to take immediate action to boycott. The association is also actively promoting its cause on social media platforms, aiming to increase the number of petition signatures to the fullest extent possible. Moreover, real-life testimonies are being shared to illustrate how e-cigarettes have helped individuals quit smoking and enhance their quality of life.

 

John Dunne, the General Secretary of the Association, stated that "banning heavyweight e-cigarettes and flavored e-cigarettes could potentially be the most severe setback to public health in this century, and may even set back the progress towards smoke-free environments by several years.

 

He emphasized the importance of not allowing these products to fall into the hands of minors and preventing teenagers from being exposed to e-cigarettes. However, it must not be at the expense of sacrificing the possibility of adult smokers quitting cigarettes.

 

Furthermore, Deng En also expressed that if the ban on disposable products or fruit-flavored e-cigarettes is implemented, it could potentially fuel a rapid increase in black market sales, providing an economic source for criminals and potentially giving rise to unregulated and potentially hazardous illegal products. Similar situations have already been witnessed in countries like Australia.

 

To this end, the association has specifically initiated this petition campaign to provide a platform for millions of adult individuals who have successfully quit smoking through disposable e-cigarettes and fruit-flavored e-cigarettes to have a voice.

 

The new petition initiative is part of the "Save Vaping, Save Lives" campaign, which also includes providing information to association members, encouraging and mobilizing e-cigarette users to participate in government consultations on youth e-cigarette use. Further details about the "Save Vaping, Save Lives" campaign and the petition can be found on the official website of the UK E-Cigarette industry association.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
Key provisions of the UK's Tobacco and Vapes Act 2026 will take effect on Oct. 29, extending an age-18 sales restriction to all vaping and non-medicinal nicotine products. In England, Wales and Northern Ireland, the change brings zero-nicotine vapes within statutory age-of-sale rules and also covers products including nicotine pouches, strips and pearls. The law will also prohibit proxy purchasing for under-18s, consumer-facing vending machines, promotional giveaways and substantial discounts intended to promote vaping and nicotine products.
Regulations
Oct.10
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23